Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow

被引:0
|
作者
Panetta, J. V. [1 ]
Veltchev, I. [1 ]
Horwitz, E. [1 ]
Hallman, M. [1 ]
Wong, K. [1 ]
Price, R. A. [1 ]
Ma, C. M. C. [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA
关键词
modality combinations: Varian Varisource/US; Elekta microSelectron/CT; ULTRASOUND; MONOTHERAPY; CANCER; CT; DOSIMETRY; PROGRAM;
D O I
10.1016/j.brachy.2024.08.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: High dose rate brachytherapy (HDR-BT) has been shown to be an effective treatment for prostate cancer, with treatment plan quality dependent on a number of factors. In this work, we report on the overall performance of our ultrasound (US)-based workflow and the impact of several treatment-specific variables. METHODS AND MATERIALS: Patients who underwent HDR-BT (boost, monotherapy, and retreatment) using Varian Bravos/US from 2021 to 2023 were sampled for this study. Treatment plan quality was analyzed and plans were categorized with regard to a number of metrics, including: prostate volume, treating physician, planning physicist, number of needles included, estimated planning time, rectum-prostate separation, and bladder-prostate separation. The performance of this program was compared to the performance of our program using previously used RESULTS: Plan quality for our Bravos/US workflow was shown to be consistently above acceptability criteria for all personnel involved; on average: prostate V100%: 98.9% f 0.1%, rectum V75%: 0.04 f 0.01 cc, bladder V75%: 0.06 f 0.01cc, urethra V125%: 0.00 f 0.00 cc. Prostate coverage was statistically improved with this workflow compared to that using our previous modalities. There was a statistical correlation between organ-at-risk sparing/prostate coverage ratio and prostate volume, number of needles/prostate volume, bladder-prostate separation, and rectum-prostate separation. There was no correlation between plan quality and planning time. CONCLUSIONS: Our US-based HDR-BT program led to target coverage and organ-at-risk sparing that exceeded department thresholds. Results were acceptable regardless of the personnel involved and improved plan quality was obtained using more needles/prostate volume and increased spacing between the prostate and the rectum and bladder. (c) 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 50 条
  • [31] High-Dose-Rate Brachytherapy in the Curative Treatment of Patients With Localized Prostate Cancer
    Pisansky, Thomas M.
    Gold, Douglas G.
    Furutani, Keith M.
    Macdonald, O. Kenneth
    McLaren, Robert H.
    Mynderse, Lance A.
    Wilson, Torrence M.
    Hebl, James R.
    Choo, Richard
    MAYO CLINIC PROCEEDINGS, 2008, 83 (12) : 1364 - 1372
  • [32] High dose rate brachytherapy as a boost for the treatment of localized prostate cancer - Editorial comment
    Hsu, I-Chow
    JOURNAL OF UROLOGY, 2007, 177 (01): : 127 - 127
  • [33] High dose rate brachytherapy as monotherapy for localised prostate cancer
    Strouthos, Iosif
    Tselis, Nikolaos
    Chatzikonstantinou, Georgios
    Butt, Saeed
    Baltas, Dimos
    Bon, Dimitra
    Milickovic, Natasa
    Zamboglou, Nikolaos
    RADIOTHERAPY AND ONCOLOGY, 2018, 126 (02) : 270 - 277
  • [34] High-dose-rate brachytherapy as monotherapy for prostate cancer
    Demanes, D. Jeffrey
    Ghilezan, Michel I.
    BRACHYTHERAPY, 2014, 13 (06) : 529 - 541
  • [35] High-dose-rate brachytherapy as monotherapy in prostate cancer
    Rebecca Kelsey
    Nature Reviews Urology, 2015, 12 (7) : 359 - 359
  • [36] Dosimetry modelling for focal high dose rate prostate brachytherapy
    Mason, J.
    Al-Qaisieh, B.
    Thwaites, D. I.
    Bownes, P.
    Henry, A.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S153 - S153
  • [38] High Dose Rate Brachytherapy for Prostate Cancer - Physical Aspects
    Miszczak, Dorota
    Dabrowski, Tomasz
    Nahajowski, Damian
    Lesiak, Jan
    Kisielewiez, Kamil
    Kudzia, Roksana
    Kukielka, Andrzej
    Walasek, Tomasz
    Byrski, Edward
    Waligorski, Michal
    SOME ASPECTS OF MEDICAL PHYSICS - IN VIVO AND IN VITRO STUDIES, 2010, 1 : 182 - 185
  • [39] Developing a High-Dose-Rate Prostate Brachytherapy Program
    Waring, Jayne
    Gosselin, Tracy
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 199 - 205
  • [40] Brachytherapy guideline in prostate cancer (high and low dose rate)
    Hanna, Samir Abdallahah
    Pimentel, Leonardo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (04): : 293 - 298